Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Dendreon Pharmaceuticals LLC
FDA Inspection
•Dendreon Pharmaceuticals LLC•March 25, 2026

Dendreon Pharmaceuticals LLC – FDA Inspection, Mar 25, 2026

Record Details

This FDA Inspection record concerns Dendreon Pharmaceuticals LLC, with an inspection on March 25, 2026, issued by the Los Angeles District Office, covering biologics.

Company
Dendreon Pharmaceuticals LLC
Inspection Date
March 25, 2026
Product Type
Biologics
Office
Los Angeles District Office
People
  • Benny Mathews (Issuing Officer)
  • Emily B. Camire (Issuing Officer)
  • Esther A. Ofori (Issuing Officer)
  • Lizaida Perez (FDA Personnel)
  • Sony Mathews (FDA Associated Person)
View Company Profile

ID · 18d0f24c-cd63-43db-ac7c-9cb2177b0278

Inspection Facts

Inspection number
1303248
FDA center
Biologics
Project area
Human Cellular, Tissue, and Gene Therapies
Outcome
Form 483 issued, view the record

FDA Citations

9
  1. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  2. 21 CFR 211.113(b)Procedures for sterile drug products
  3. 21 CFR 211.115(b)Reprocessing/quality control unit
  4. 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
  5. 21 CFR 211.192Written record of investigation incomplete
  6. 21 CFR 211.194(a)(8)Second person sign off
  7. 21 CFR 211.22(d)Procedures not in writing, fully followed
  8. 21 CFR 211.25(a)Training , Education , Experience overall
  9. 21 CFR 211.94(a)Reactive/Additive/Absorptive Containers/Closures

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Dendreon Pharmaceuticals LLC

5
DateClassificationOfficeProject area
August 10, 2023VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
November 8, 2019VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
January 19, 2018VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
January 22, 2016VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
November 15, 2012VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
Other documents for Dendreon Pharmaceuticals LLC
  • FDA Inspection 1214688 - 2023-08-10
  • FDA Inspection 1109236 - 2019-11-08
  • FDA Inspection 1038072 - 2018-01-19
  • FDA Inspection 961300 - 2016-01-22
  • FDA Inspection 848259 - 2012-11-15

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dendreon Pharmaceuticals LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.